Delivery Order SPE2DB24D3013-SPE2DB25FFMBR
Award Date 6/2/25
Potential Completion Date 6/3/25
Potential Value $6.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 26, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a ceiling value of $4,557.08 and an ultimate completion date of November 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,639.94 by the Defense Logistics Agency (DLA) for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, awarded on August 26, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, and this award was made through open competition without a set-aside designation. This delivery...
- AmerisourceBergen Drug Corp was awarded a competitive delivery order on December 11, 2025, by the Defense Logistics Agency for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials with a ceiling value of $2,426.72 and a firm fixed price structure. The order is scheduled for ultimate completion by December 12, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a delivery order for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials with a ceiling value of $12,533.20 by the Defense Logistics Agency on August 15, 2025. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,784.73 and an ultimate completion date of September 16, 2025. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This award was competitively awarded with no set-aside designation and...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with a ceiling value of $22,473.32 and an ultimate completion date of October 31, 2025. This is a firm fixed price, non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 18, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. The contract is valued at $3,759.96 and carries a firm fixed price with an ultimate completion date of August 19, 2025. The award utilized competitive procurement procedures with no set-aside designation. The place of performance is identified as the vendor's corporate office in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on May 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication. The contract, valued at $1,566.65 with a firm fixed-price structure, is scheduled for completion by June 2, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,821.00 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of December 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. The award represents a single delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This order, valued at $15,173.15 with a firm fixed price contract type, is scheduled for completion by September 29, 2025, and will be fulfilled from the company's Conshohocken, Pennsylvania location. The award was competitively procured with no set-aside designation and represents a delivery order against...